Works matching AU Ntanasis-Stathopoulos, Ioannis

Results: 173
    1
    2

    Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin.

    Published in:
    Basic Research in Cardiology, 2025, v. 120, n. 1, p. 263, doi. 10.1007/s00395-024-01046-0
    By:
    • Efentakis, Panagiotis;
    • Choustoulaki, Angeliki;
    • Kwiatkowski, Grzegorz;
    • Varela, Aimilia;
    • Kostopoulos, Ioannis V.;
    • Tsekenis, George;
    • Ntanasis-Stathopoulos, Ioannis;
    • Georgoulis, Anastasios;
    • Vorgias, Constantinos E.;
    • Gakiopoulou, Harikleia;
    • Briasoulis, Alexandros;
    • Davos, Constantinos H.;
    • Kostomitsopoulos, Nikolaos;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios Athanasios;
    • Terpos, Evangelos;
    • Chłopicki, Stefan;
    • Gavriatopoulou, Maria;
    • Andreadou, Ioanna
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRF<sup>HisGTG</sup> results in patients' poor treatment outcome.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1790, doi. 10.1111/bjh.19332
    By:
    • Soureas, Konstantinos;
    • Papadimitriou, Maria‐Alexandra;
    • Malandrakis, Panagiotis;
    • Papanota, Aristea‐Maria;
    • Adamopoulos, Panagiotis G.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Liacos, Christine‐Ivy;
    • Gavriatopoulou, Maria;
    • Sideris, Diamantis C.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos;
    • Avgeris, Margaritis
    Publication type:
    Article
    11

    Thrombotic and bleeding complications in patients with AL amyloidosis.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1816, doi. 10.1111/bjh.19331
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Sotiria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    12

    Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 3, p. 411, doi. 10.1111/bjh.19042
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Papanikolaou, Asimina;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    13

    Immune response and adverse events after vaccination against SARS‐CoV‐2 in adult patients with transfusion‐dependent thalassaemia.

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 5, p. 576, doi. 10.1111/bjh.18146
    By:
    • Delaporta, Polyxeni;
    • Terpos, Evangelos;
    • Solomou, Elena E.;
    • Gumeni, Sentiljana;
    • Nitsa, Evangelia;
    • Apostolakou, Filia;
    • Kyriakopoulou, Dimitra;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Papassotiriou, Ioannis;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.;
    • Kattamis, Antonis
    Publication type:
    Article
    14

    Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Fotiou, Despina;
    • Papanagnou, Eleni‐Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios
    Publication type:
    Article
    15
    16

    Daratumumab‐based therapy for patients with monoclonal gammopathy of renal significance.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 1, p. 113, doi. 10.1111/bjh.17052
    By:
    • Kastritis, Efstathios;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Psimenou, Erasmia;
    • Gakiopoulou, Charikleia;
    • Marinaki, Smaragdi;
    • Gatou, Anastasia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Kostopoulos, Ioannis V.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    17

    Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.

    Published in:
    Clinical & Experimental Medicine, 2022, v. 22, n. 2, p. 319, doi. 10.1007/s10238-021-00746-4
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Ntanasis-Stathopoulos, Ioannis;
    • Sklirou, Aimilia D.;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    18

    COVID-19: time to flatten the infodemic curve.

    Published in:
    Clinical & Experimental Medicine, 2021, v. 21, n. 2, p. 161, doi. 10.1007/s10238-020-00680-x
    By:
    • Tentolouris, Anastasios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Vlachakis, Panayotis K.;
    • Tsilimigras, Diamantis I.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    19

    Emerging treatment strategies for COVID-19 infection.

    Published in:
    Clinical & Experimental Medicine, 2021, v. 21, n. 2, p. 167, doi. 10.1007/s10238-020-00671-y
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Korompoki, Eleni;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Tzanninis, Ioannis-Georgios;
    • Psaltopoulou, Theodora;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    20

    Organ-specific manifestations of COVID-19 infection.

    Published in:
    Clinical & Experimental Medicine, 2020, v. 20, n. 4, p. 493, doi. 10.1007/s10238-020-00648-x
    By:
    • Gavriatopoulou, Maria;
    • Korompoki, Eleni;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Psaltopoulou, Theodora;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    21
    22

    Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma.

    Published in:
    EJHaem, 2025, v. 6, n. 1, p. 1, doi. 10.1002/jha2.889
    By:
    • Terpos, Evangelos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A;
    • Kastritis, Efstathios
    Publication type:
    Article
    23

    ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 677, doi. 10.1002/jha2.903
    By:
    • Papatsirou, Maria;
    • Kontos, Christos K.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Liacos, Christine‐Ivy;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    31

    Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 844, doi. 10.1016/j.clml.2023.07.013
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Solia, Eirini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Kokkali, Nikoleta;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Syrigou, Rodanthi;
    • Fotiou, Despina;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    32

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    33

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    34

    MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S441, doi. 10.1016/S2152-2650(21)01982-0
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    35

    Poster: MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S253, doi. 10.1016/S2152-2650(21)01584-6
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    36
    37
    38
    39

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    40
    41

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    42

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    43

    Flow-Mediated Dilatation (FMD) and Aortic Blood Pressure May Predict Cardiovascular Adverse Events During Carfilzomib Therapy: A Prospective Study in Relapsed/Refractory Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.433
    By:
    • Kastritis, Efstathios;
    • Laina, Aggeliki;
    • Gavriatopoulou, Maria;
    • Georgiopoulos, Georgios;
    • Fotiou, Despina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Makris, Nikolaos;
    • Papanota, Aristea-Maria;
    • Trougakos, Ioannis P.;
    • Kotsopoulou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    44

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    45

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    46
    47

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    48

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S325, doi. 10.1016/j.clml.2019.07.310
    By:
    • Papanota, Aristea-Maria;
    • Kastritis, Efstathios;
    • Papassotiriou, Gerasimos-Petros;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Margeli, Alexandra;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    49
    50

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article